4-en-6 - β-ol-3-one通过降低E2F1降低肝癌细胞活力，诱导凋亡和铁凋亡

IF 4.6 Q2 MATERIALS SCIENCE, BIOMATERIALS

ACS Applied Bio Materials Pub Date : 2023-11-22 DOI:10.1080/19768354.2023.2282224

Zhiyun Zhang, Jian Wang, Weiping Wan, Zhengchao Shen, Aixue Zuo, Rong Chen, Qinyi Wu, Enli Cai, Feng Huang, Rongping Zhang, Xinan Shi

{"title":"4-en-6 - β-ol-3-one通过降低E2F1降低肝癌细胞活力，诱导凋亡和铁凋亡","authors":"Zhiyun Zhang, Jian Wang, Weiping Wan, Zhengchao Shen, Aixue Zuo, Rong Chen, Qinyi Wu, Enli Cai, Feng Huang, Rongping Zhang, Xinan Shi","doi":"10.1080/19768354.2023.2282224","DOIUrl":null,"url":null,"abstract":"Hepatocellular carcinoma (HCC) is a frequently occurring malignant gastrointestinal cancer. The 5-year survival rate of HCC is still below 8%, and thus, identifying more effective therapeutic metho...","PeriodicalId":2,"journal":{"name":"ACS Applied Bio Materials","volume":null,"pages":null},"PeriodicalIF":4.6000,"publicationDate":"2023-11-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Stigmast-4-en-6β-ol-3-one decreases viability and induces apoptosis and ferroptosis in liver cancer cells by reducing E2F1\",\"authors\":\"Zhiyun Zhang, Jian Wang, Weiping Wan, Zhengchao Shen, Aixue Zuo, Rong Chen, Qinyi Wu, Enli Cai, Feng Huang, Rongping Zhang, Xinan Shi\",\"doi\":\"10.1080/19768354.2023.2282224\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Hepatocellular carcinoma (HCC) is a frequently occurring malignant gastrointestinal cancer. The 5-year survival rate of HCC is still below 8%, and thus, identifying more effective therapeutic metho...\",\"PeriodicalId\":2,\"journal\":{\"name\":\"ACS Applied Bio Materials\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":4.6000,\"publicationDate\":\"2023-11-22\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"ACS Applied Bio Materials\",\"FirstCategoryId\":\"99\",\"ListUrlMain\":\"https://doi.org/10.1080/19768354.2023.2282224\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"MATERIALS SCIENCE, BIOMATERIALS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"ACS Applied Bio Materials","FirstCategoryId":"99","ListUrlMain":"https://doi.org/10.1080/19768354.2023.2282224","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MATERIALS SCIENCE, BIOMATERIALS","Score":null,"Total":0}

引用次数: 0

摘要

肝细胞癌(HCC)是一种多发病的胃肠道恶性肿瘤。HCC的5年生存率仍低于8%，因此，寻找更有效的治疗方法…

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Stigmast-4-en-6β-ol-3-one decreases viability and induces apoptosis and ferroptosis in liver cancer cells by reducing E2F1

Hepatocellular carcinoma (HCC) is a frequently occurring malignant gastrointestinal cancer. The 5-year survival rate of HCC is still below 8%, and thus, identifying more effective therapeutic metho...

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

ACS Applied Bio Materials Chemistry-Chemistry (all)

CiteScore

9.40

自引率

2.10%

发文量

464